Advanced disease stage was the strongest predictor of high first-year healthcare costs in Canadian patients with head and neck cancer, a recent analysis found. Patients with stage IV disease had an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback